亚洲精品国产成人一区二区_欧美性xxxxx极品娇小_国产欧美久久一区二区三区_日日麻批免费40分钟无码

Mabwell Established a Licensing and Commercialization Agreement of MAILISHU and 9MW0321 for Egypt Market

Release time:Jun 27, 2023

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that it has established a licensing and commercialization agreement with a strategic business partner ("the partner") in Egypt for its products, MAILISHU (Denosumab solution for injection, a biosimilar of Prolia?) and 9MW0321 (Denosumab solution for injection, a biosimilar of XGEVA?). Under the agreement, the partner has the exclusive sales rights for MAILISHU and 9MW0321 in Egypt, while Mabwell is responsible for the development, production, and commercial supply for MAILISHU and 9MW0321.

MAILISHU has been approved for marketing in China by National Medical Products Administration (NMPA) in March 2023. Based on the comparative and progressive development principle, comprehensive evaluation of pharmaceutical, non-clinical and clinical comparative results demonstrated the overall similarity of MAILISHU and 9MW0321 to the original drugs in terms of quality, safety, and efficacy. The partner is responsible for submitting the marketing application for MAILISHU and 9MW0321 in Egypt. Previously, Mabwell had granted the exclusive sales rights of JUNMAIKANG (Adalimumab solution for injection, a biosimilar of HUMIRA?) to the partner for Egypt market.

Mr. Huiguo Hu, Board Member and Senior Vice President of Mabwell, said, “We are pleased that a commercial cooperation has been established for Egypt market for the World's second approved biosimilars of denosumab developed by Mabwell. Egypt has a population of over 100 million and has always been one of the main gateways for drugs to enter Africa. Moreover, it is an important country in the “Belt and Road Initiative”. This new agreement following the cooperation of JUNMAIKANG? represents the full recognition of the development data of Mabwell's products. We will vigorously promote the registration and commercialization of the cooperative products in Egypt to provide high-quality drugs to more patients in the worldwide."

主站蜘蛛池模板: 通州市| 平乡县| 葫芦岛市| 诸暨市| 嘉定区| 怀宁县| 余庆县| 儋州市| 工布江达县| 平和县| 韶山市| 肃北| 开封县| 碌曲县| 砚山县| 来安县| 芦山县| 谷城县| 大洼县| 双桥区| 大悟县| 桦南县| 常熟市| 甘泉县| 航空| 广安市| 高安市| 横山县| 寿宁县| 平武县| 和林格尔县| 鸡东县| 互助| 杭州市| 通辽市| 新乡县| 云林县| 公安县| 三原县| 连山| 兖州市|